$495 millionVerdict

$495 Million Verdict Against Abbott for Failing to Warn That Similac Caused NEC in Premature Infant

Verdict · 22nd Judicial Circuit, St. Louis, Missouri (Case No. 2322-CC01251) · 2024

After trial: Abbott appealed and lost: a Missouri appeals court upheld the $495 million verdict. Rather than pay the judgment plus accrued interest, Abbott in August 2026 reached settlement agreements resolving the Gill case together with roughly 2,000 other NEC claims for an aggregate of about $670 million; the portion paid to the Gill family specifically was not disclosed.

Won by TorHoerman Law.

A St. Louis jury awarded $495 million against Abbott Laboratories after finding the company failed to warn that its Similac cow's milk formula could cause necrotizing enterocolitis in premature infants.

What happened

In the summer of 2023, Margo Gill filed suit in St. Louis on behalf of her daughter Robynn, a premature infant who had been admitted to a neonatal intensive care unit shortly after birth. While in the NICU, Robynn received Abbott Laboratories' Similac Special Care 24, a cow's milk-based formula marketed for premature and low-birth-weight newborns. She subsequently developed necrotizing enterocolitis, a life-threatening condition in which intestinal tissue dies. The disease left Robynn with severe and permanent brain damage.

The central allegation was straightforward: Abbott had known for years that cow's milk-based formula significantly raises the risk of NEC in premature infants, yet the company placed no warning on Similac products. Medical literature linking cow's milk formula to NEC in preterm newborns had accumulated over decades, and internal Abbott documents were put before the jury to show that executives were aware of the risk association while choosing not to warn neonatologists, hospital staff, or parents.

Trial ran from July 9 to July 26, 2024, before Judge Michael Noble in the Civil Courts Building in St. Louis. Jacob Plattenberger of TorHoerman Law served as lead trial counsel for the Gill family, alongside co-counsel John 'Jack' Garvey of Stranch, Jennings and Garvey. The defense, handled by Kirkland and Ellis and Winston and Strawn, argued that Robynn's complications stemmed from her prematurity itself, pointing to prior surgeries, hemorrhages, and a hypoxic event, not the formula.

The jury rejected Abbott's causation defense and returned a verdict of $495 million: $95 million in compensatory damages and $400 million in punitive damages. Abbott publicly disputed the finding, stating it disagreed with the decision and would pursue every available avenue to have it overturned. In May 2026 the Missouri Court of Appeals, Eastern District, affirmed the verdict and later declined to transfer the case to the Missouri Supreme Court, leaving the $495 million award intact.

The Gill case was the first plaintiff verdict in the NEC infant formula litigation to reach a jury in Missouri. Tor Hoerman, founding attorney of TorHoerman Law, had led the firm's NEC docket, which included hundreds of similar claims against Abbott and Mead Johnson filed on behalf of families across the country.

Sources

This account is drawn from contemporaneous public reporting and the court record.

More proven verdicts from TorHoerman Law

All TorHoerman Law proven verdicts →
$650 millionSettlementGroup recoveryProduct LiabilityIL

Boehringer Ingelheim agreed to pay $650 million in May 2014 to resolve approximately 4,000 federal lawsuits claiming the blood thinner Pradaxa caused life-threatening bleeding injuries without adequate warnings, in an MDL presided over by Judge David Herndon in the Southern District of Illinois where the court appointed TorHoerman Law's Tor Hoerman as one of five plaintiffs' co-lead counsel.

2014 · U.S. District Court, Southern District of Illinois (MDL No. 2385)Read the full story →
$25 millionVerdictProduct LiabilityCA

A Los Angeles jury unanimously held Conagra Brands fully liable and awarded $25 million to Roland Esparza, who developed severe bronchiolitis obliterans after years of daily exposure to butter-flavored PAM cooking spray fumes.

2026 · Los Angeles County Superior CourtRead the full story →
$25 millionVerdictWrongful DeathMO

A federal jury in St. Louis awarded $25 million to the parents of a two-year-old girl who drowned after climbing into a Bestway above-ground pool using an exterior nylon strap the manufacturer had built into the design.

2025 · U.S. District Court, Eastern District of Missouri (Case No. 4:22-cv-00050)Read the full story →
~$2 millionVerdictWorkplace InjuryMO

A St. Louis jury found diacetyl distributor Elan Chemical Company liable for the debilitating lung disease suffered by two food-flavoring plant workers, returning a $1 million verdict for each man in March 2023.

2023 · St. Louis City Circuit Court (Case No. 1722-CC01186)Read the full story →

Related product liability verdicts

$25 billionSettlementGroup recoveryNY

Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.

Sullivan Papain Block McManus Coffinas & Cannavo1998 · New York State (Master Settlement Agreement)Read the full story →
$11.3 billionSettlementGroup recoveryFL

C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.

The Yerrid Law Firm, Terrell Hogan and The Maher Law Firm1997 · Florida (State v. American Tobacco Co.)Read the full story →
$10.9 billionSettlementGroup recoveryCA

As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.

Weitz & Luxenberg2020 · U.S. District Court, Northern District of California (MDL No. 2741)Read the full story →
$5.5 billionSettlementGroup recoveryNJ

After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.

Ashcraft & Gerel, LLP2026 · D.N.J. MDL No. 2738Read the full story →